Q9H8M2 (BRD9_HUMAN) Homo sapiens (Human)

Bromodomain-containing protein 9 UniProtKBInterProSTRINGInteractive Modelling

597 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 1; Isoform 6)

Available Structures

48 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of BRD9 Bromodomain bound to a butyryllysine peptide
4yy6
 Heteromer
P62805; 		138-239
Assess
Crystal structure of BRD9 Bromodomain bound to a crotonyllysine peptide
4yyh
 Heteromer
P62805; 		138-239
Assess
Crystal structure of BRD9 Bromodomain bound to a crotonyllysine peptide
4yyd
 Heteromer
P62805; 		139-239
Assess
Crystal structure of BRD9 Bromodomain bound to a crotonyllysine peptide
4yyk
 Heteromer
P62805; 		138-238
Assess
Crystal structure of BRD9 Bromodomain bound to a butyryllysine peptide
4yyj
 Heteromer
P62805; 		138-238
Assess
Crystal structure of BRD9 Bromodomain bound to an acetylated peptide
4yyi
 Heteromer
P62805; 		139-238
Assess
Crystal structure of BRD9 Bromodomain bound to a butyryllysine peptide
4yyg
 Heteromer
P62805; 		139-238
Assess
Crystal structure of human bromodomain containing 9 isoform 1 (BRD9)
3hme
homo-2-mer137-243
Assess
Crystal structure of the bromodomain of human BRD9 in complex with bromosporine (BSP)
5igm
homo-2-mer138-243
2×BMF;
Assess
Crystal structure of human BRD9 bromodomain in complex with LP99 chemical probe
5ign
homo-2-mer138-243
2×6B2;
Assess
Crystal structure of BRD9 bromodomain in complex with an indolizine ligand
5e9v
homo-2-mer138-243
2×5L0; 2×EDO;
Assess
Crystal structure of the bromodomain of human BRD9 bound to TG003
6v0s
homo-2-mer138-243
2×EAE;
Assess
Crystal Structure of BRD9 bromodomain
5twx
monomer137-250
1×7P7;
Assess
Structure of the BRD9 bromodomain and compound 27
6y7k
monomer137-243
1×OEZ; 2×EDO; 2×NA;
Assess
Crystal structure of the bromodomain of human BRD9 bound to I-BRD9
6v1b
monomer137-243
1×EDO; 1×H1B;
Assess
Structure of the BRD9 bromodomain and compound 2
6y7i
monomer137-243
1×OF8; 1×EDO;
Assess
Crystal Structure of the bromodomain of human BRD9 in complex with a triazolo-phthalazine ligand
4nqn
monomer137-243
1×Y1Z;
Assess
Structure of the BRD9 bromodomain and TP-472
6y7l
monomer137-243
1×QMG;
Assess
Structure of the BRD9 bromodomain and compound 11
6y7h
monomer137-243
1×OFK; 4×EDO;
Assess
Crystal structure of the BRD9 bromodomain with BI-7189
8ahc
monomer138-243
1×M2O;
Assess
Structure of the BRD9 bromodomain and compound 15
6y7j
monomer138-243
1×OF5;
Assess
CRYSTAL STRUCTURE OF BRD9 IN COMPLEX WITH BI-7273
5eu1
monomer138-243
1×5SW;
Assess
Crystal structure of the BRD9 bromodomain in complex with compound 4.
5f25
monomer138-243
1×5TU;
Assess
Crystal Structure of the bromodomain of BRD9 in complex with a 2-amine-9H-purine ligand
4xy8
monomer138-243
1×43U; 1×BR;
Assess
Crystal structure of the BRD9 bromodomain in complex with compound 3.
5f2p
monomer138-243
1×5TY;
Assess
Crystal structure of BRD9 bromodomain in complex with a valerolactam quinolone ligand
4z6h
monomer138-243
1×4L2;
Assess
Crystal structure of the BRD9 bromodamian in complex with BI-9564.
5f1h
monomer138-243
1×5U6;
Assess
Crystal structure of BRD9 bromodomain in complex with a substituted valerolactam quinolone ligand
4z6i
monomer138-243
1×4L3;
Assess
Crystal structure of the bromodomain of BRD9 in complex with compound 9.
5f1l
monomer138-243
1×5U2;
Assess
Crystal structure of human BRD9 bromodomain in complex with a PROTAC
6hm0
monomer138-243
1×GBW;
Assess
Crystal structure of the unliganded bromodomain of human BRD9
6uzf
monomer137-240
1×SO4; 2×EDO; 1×DMS;
Assess
BRD9 bromodomain in complex with 3-(6-(but-3-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-…
6bqa
monomer138-239
1×67C;
Assess
BRD9 in complex with Cpd1 (6-methyl-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one)
5i40
monomer138-239
4×EDO; 1×PEG; 1×67N;
Assess
Crystal structure of the bromodomain of human BRD9 bound to TP472
6v14
monomer138-239
1×QMG; 1×EDO;
Assess
BRD9 in complex with Cpd2 (N,N-dimethyl-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl…
5i7x
monomer138-238
1×67B;
Assess
BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-2-(4- methanesulfonylpiperazine-1-carbonyl)-…
4uit
monomer138-238
1×N1D;
Assess
BRD9 in complex with Cpd4 ((E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl…
5i7y
monomer138-238
1×69G;
Assess
Crystal structure of BRD9 Bromodomain bound to DMSO
4yy4
monomer139-239
1×DMS;
Assess
BRD9 with 4-chloro-2-methyl-methylamino-pyridazinone
6yqw
monomer138-238
1×82I;
Assess
BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1- thian-4-yl)-5-methyl-4-oxo-4…
4uiu
monomer138-238
1×TVU;
Assess
BROMODOMAIN OF HUMAN BRD9 WITH 4-chloro-2-methyl-5-((2-methyl-1,2,3,4-tetrahydroisoquinolin-5-yl)am…
5mky
monomer138-238
2×I0D;
Assess
BRD9 with methylpiperazinyl-benzyl-amino-dimethylpyridazinone
6yqs
monomer138-238
1×P8Z;
Assess
BRD9 with Biphenyl-methylamino-dimethylpyridazinone
6yqr
monomer138-238
1×P8W;
Assess
BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4- oxo-7-3-(trifluoromethyl)phen…
4uiv
monomer138-238
1×EDO; 1×XZB;
Assess
BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)pheny…
4uiw
monomer138-238
1×EDO; 1×H1B;
Assess
Crystal structure of BRD9 bromodomain in complex with compound EA-89
8a7i
monomer138-238
1×L8L;
Assess
Crystal structure of the BRD9 bromodomain and hit 1
5ji8
monomer139-238
1×6KT;
Assess
Crystal structure of the bromodomain of human BRD9 bound to sunitinib
6v0x
monomer138-236
1×B49;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6hm0.1.Amonomer0.61138-243
1×GBW;97.27
Assess

5 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 13hme.1.Amonomer0.7422-134
100.00
Assess
Isoform 21sum.1.Amonomer0.5434-62
17.24
Assess
Isoform 34n3w.1.Amonomer0.6623-126
28.85
Assess
Isoform 45twx.1.Amonomer0.7521-134
1×7P7;100.00
Assess
Isoform 64xy8.1.Amonomer0.55102-190
1×43U; 1×BR;95.51
Assess